REGENERON PHARMACEUTICALS, INC.【REGN】Balance sheet

Market cap

$86B

P/E ratio

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	113	484	230	536	649	809	535	813	1,480	1,630	2,207	2,898	3,119	2,738	2,489
Marketable securities, current	137	43	78	158	252	236	503	597	1,342	1,597	1,393	2,809	4,636	8,115	6,524
Total cash & short-term investments	249	527	308	694	900	1,045	1,039	1,410	2,822	3,227	3,601	5,707	7,756	10,853	9,013
Accounts receivable, net	14	28	593	787	739	1,152	1,343	1,539	1,724	2,100	3,112	6,037	5,329	5,667	6,212
Inventories	-	-	-	70	129	239	399	726	1,151	1,416	1,917	1,951	2,402	2,581	3,087
Total current assets	358	653	1,206	1,797	2,167	2,915	3,180	4,335	6,448	7,689	9,779	14,015	15,884	19,479	18,661
Property, plant and equipment, net	347	368	380	527	974	1,594	2,083	2,359	2,576	-	-	-	-	-	-
Marketable securities, non-current	370	276	271	390	460	632	864	1,486	1,755	3,257	3,136	6,838	6,592	5,397	8,900
Total non-current assets	732	671	874	1,154	1,704	2,694	3,793	4,429	5,287	7,116	7,384	11,420	13,330	13,601	19,099
Total assets	1,089	1,324	2,080	2,951	3,872	5,609	6,973	8,764	11,735	14,805	17,163	25,435	29,215	33,080	37,759
Accounts payable	-	-	-	-	-	-	-	-	218	418	476	564	589	607	790
Total current liabilities	109	148	164	299	655	811	1,241	1,135	1,443	2,097	2,697	3,933	3,141	3,423	3,944
Long-term debt, non-current	-	-	-	-	-	-	-	-	-	-	1,979	1,980	1,981	1,983	1,984
Total non-current liabilities	453	690	672	700	675	1,143	1,283	1,485	1,534	1,619	3,441	2,734	3,409	3,684	4,462
Total liabilities	562	838	835	999	1,330	1,954	2,524	2,620	2,977	3,716	6,138	6,666	6,551	7,107	8,406
Common stock and paid-in capital	1,576	1,755	1,764	2,046	2,451	3,100	3,030	3,513	3,912	4,429	6,716	8,088	9,949	11,354	12,856
Retained earnings	-1,046	-1,267	-517	-93	255	853	1,748	2,947	5,254	7,380	10,893	18,968	23,307	27,260	31,673
Stockholders' equity	528	486	1,245	1,952	2,542	3,655	4,449	6,144	8,757	11,090	11,025	18,769	22,664	25,973	29,354
Total debt	-	-	-	-	-	-	-	-	-	-	1,979	1,980	1,981	1,983	1,984
Net debt	-	-	-	-	-	-	-	-	-	-	-1,622	-3,727	-5,774	-8,870	-7,029
D/E ratio (%)	-	-	-	-	-	-	-	-	-	-	17.9	10.5	8.7	7.6	6.8
Working capital	-	-	-	-	-	-	-	-

Raw aggregated data